Kainic Acid-Induced Neurodegenerative Model: Potentials and Limitations
暂无分享,去创建一个
[1] Sung-soo Kim,et al. Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice , 2010, Peptides.
[2] Xi Liu,et al. Structural insights into the assembly and activation of IL-1β with its receptors , 2010, Nature Immunology.
[3] H. Neumann,et al. Protective effects of microglia in multiple sclerosis , 2010, Experimental Neurology.
[4] M. Pallàs,et al. Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment , 2010, Journal of neurochemistry.
[5] S. Jinap,et al. Glutamate. Its applications in food and contribution to health , 2010, Appetite.
[6] Dong Hyun Kim,et al. Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice , 2010, Neuropharmacology.
[7] P. Schauwecker. Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain , 2010, Experimental Neurology.
[8] Wei Wang,et al. Excitotoxicity of TNFα derived from KA activated microglia on hippocampal neurons in vitro and in vivo , 2010, Journal of neurochemistry.
[9] Michael T. Heneka,et al. Neuroglia in neurodegeneration , 2010, Brain Research Reviews.
[10] C. Colton,et al. Assessing activation states in microglia. , 2010, CNS & neurological disorders drug targets.
[11] H. Jia,et al. Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. , 2010, Free radical biology & medicine.
[12] D. Baker,et al. Inflammation in neurodegenerative diseases , 2010, Immunology.
[13] D. Cleveland,et al. Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.
[14] S. Johann,et al. Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins , 2009, Neurochemistry International.
[15] P Jeffrey Conn,et al. Glutamate receptors as therapeutic targets for Parkinson's disease. , 2009, CNS & neurological disorders drug targets.
[16] C. Beltramino,et al. Differential role of gonadal hormones on kainic acid–induced neurodegeneration in medial amygdaloid nucleus of female and male rats , 2009, Neuroscience.
[17] Wei Wang,et al. Kainic Acid-Activated Microglia Mediate Increased Excitability of Rat Hippocampal Neurons in vitro and in vivo: Crucial Role of Interleukin-1beta , 2009, Neuroimmunomodulation.
[18] M. Swamy,et al. Nitric oxide (NO), citrulline–NO cycle enzymes, glutamine synthetase, and oxidative status in kainic acid–mediated excitotoxicity in rat brain , 2009, Drug and chemical toxicology.
[19] D. Dexter,et al. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6‐hydroxydopamine model of Parkinson’s disease , 2009, Journal of neurochemistry.
[20] Myong-Jo Kim,et al. Kainic Acid-induced Neuronal Death is Attenuated by Aminoguanidine but Aggravated by L-NAME in Mouse Hippocampus. , 2009, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.
[21] S. Hino,et al. Increased vulnerability of hippocampal pyramidal neurons to the toxicity of kainic acid in OASIS‐deficient mice , 2009, Journal of neurochemistry.
[22] M. Knutson,et al. Uptake of Materials from the Nasal Cavity into the Blood and Brain , 2009, Annals of the New York Academy of Sciences.
[23] Jeffrey A. Johnson,et al. The Nrf2–ARE cytoprotective pathway in astrocytes , 2009, Expert Reviews in Molecular Medicine.
[24] C. Wiley,et al. Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease , 2009, Journal of Neuroimmune Pharmacology.
[25] J. Bennett,et al. Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis: Therapeutic Implications , 2009, Clinical neuropharmacology.
[26] M. Sikorska,et al. Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity , 2009, Neurobiology of Disease.
[27] R. Hohlfeld,et al. Neuro-immune crosstalk in CNS diseases , 2009, Neuroscience.
[28] Graham L. Collingridge,et al. A nomenclature for ligand-gated ion channels , 2009, Neuropharmacology.
[29] C. Mulle,et al. Kainate receptors in epilepsy and excitotoxicity , 2009, Neuroscience.
[30] Qiang Wang,et al. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats , 2009, Neuroscience Letters.
[31] DelindaA . Johnson,et al. Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis , 2008, The Journal of Neuroscience.
[32] G. Dakubo,et al. Control of glial precursor cell development in the mouse optic nerve by sonic hedgehog from retinal ganglion cells , 2008, Brain Research.
[33] W. Löscher,et al. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate , 2008, Experimental Neurology.
[34] T. Jin,et al. TNF‐α receptor 1 deficiency enhances kainic acid–induced hippocampal injury in mice , 2008, Journal of neuroscience research.
[35] H. Tamai,et al. Edaravone prevents kainic acid-induced neuronal death , 2008, Brain Research.
[36] B. Bahr,et al. Calpain activation is involved in early caspase‐independent neurodegeneration in the hippocampus following status epilepticus , 2008, Journal of neurochemistry.
[37] O. Pulido,et al. Regional Susceptibility to Domoic Acid in Primary Astrocyte Cells Cultured from the Brain Stem and Hippocampus , 2008, Marine drugs.
[38] N. Nishiyama,et al. Ablation of p27 enhance kainate-induced seizure and hippocampal degeneration , 2007, Neuroreport.
[39] J. Fessel,et al. Seizure‐induced formation of isofurans: novel products of lipid peroxidation whose formation is positively modulated by oxygen tension , 2007, Journal of neurochemistry.
[40] J. Hablitz,et al. Pre- and postsynaptic effects of kainate on layer II/III pyramidal cells in rat neocortex , 2007, Neuropharmacology.
[41] K. Yamagata,et al. Roles of prostaglandin synthesis in excitotoxic brain diseases , 2007, Neurochemistry International.
[42] A. Sano,et al. Differences in two mice strains on kainic acid-induced amygdalar seizures. , 2007, Biochemical and biophysical research communications.
[43] B. Winblad,et al. IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice due to an overcompensation by IL-12 , 2007, Experimental Neurology.
[44] S. Hino,et al. A novel ER stress transducer, OASIS, expressed in astrocytes. , 2007, Antioxidants & redox signaling.
[45] F. Kirchhoff,et al. Glia: the fulcrum of brain diseases , 2007, Cell Death and Differentiation.
[46] N. Belluardo,et al. Endoplasmic Reticulum Stress Inhibition Protects against Excitotoxic Neuronal Injury in the Rat Brain , 2007, The Journal of Neuroscience.
[47] N. Nishiyama,et al. Calpain activation is required for glutamate‐induced p27 down‐regulation in cultured cortical neurons , 2006, Journal of neurochemistry.
[48] O. Steward,et al. Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains , 2006, The European journal of neuroscience.
[49] N. Nishiyama,et al. p27 small interfering RNA induces cell death through elevating cell cycle activity in cultured cortical neurons: a proof-of-concept study , 2006, Cellular and Molecular Life Sciences CMLS.
[50] K. Yamagata,et al. Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region , 2006, Neuroscience Research.
[51] D. Pei,et al. Neuroprotection of Tat-GluR6-9c against Neuronal Death Induced by Kainate in Rat Hippocampus via Nuclear and Non-nuclear Pathways* , 2006, Journal of Biological Chemistry.
[52] Tian-Le Xu,et al. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence. , 2006, Brain : a journal of neurology.
[53] G. Smith,et al. Genetic background regulates semaphorin gene expression and epileptogenesis in mouse brain after kainic acid status epilepticus , 2005, Neuroscience.
[54] Jun Chen,et al. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus , 2005, Brain Research.
[55] J. Velíšková,et al. Inflammatory Response and Glia Activation in Developing Rat Hippocampus after Status Epilepticus , 2005, Epilepsia.
[56] A. Vezzani,et al. Tumor necrosis factor‐α inhibits seizures in mice via p75 receptors , 2005 .
[57] S. O’Mara,et al. Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor , 2005, Behavioural Brain Research.
[58] J. Kemp,et al. Ionotropic and metabotropic glutamate receptor structure and pharmacology , 2005, Psychopharmacology.
[59] B. Winblad,et al. Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice. , 2005, Journal of neurobiology.
[60] S. O’Mara,et al. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration , 2004, Neuroscience.
[61] T. Bártfai,et al. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment , 2004, Neuroscience.
[62] M. Pallàs,et al. p21WAF1/Cip1 is not involved in kainic acid-induced apoptosis in murine cerebellar granule cells , 2004, Brain Research.
[63] B. Winblad,et al. IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice , 2004, Neurobiology of Disease.
[64] Jui-Wei Lin,et al. Mitochondrial Dysfunction and Ultrastructural Damage in the Hippocampus during Kainic Acid–induced Status Epilepticus in the Rat , 2004, Epilepsia.
[65] H. Okamura,et al. Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices , 2004, Brain Research.
[66] A. Rodríguez-Moreno,et al. Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus , 2004, The Journal of physiology.
[67] M. Mattson,et al. Kainic acid-induced naip expression in the hippocampus is blocked in mice lacking TNF receptors. , 2004, Brain research. Molecular brain research.
[68] Giovambattista De Sarro,et al. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice , 2004, Pharmacology Biochemistry and Behavior.
[69] M. Randić,et al. Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit , 2004, The Journal of physiology.
[70] A. Vezzani. Brain Inflammation and Seizures , 2004, Epilepsy currents.
[71] Stephen D Miller,et al. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis , 2003, Journal of Neuroimmunology.
[72] M. Tymianski,et al. Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors. , 2003, Biochemical pharmacology.
[73] M. Schultzberg,et al. Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin‐1 system , 2003, Journal of cellular and molecular medicine.
[74] P. Werner,et al. AMPA/kainate receptors in mouse spinal cord cell‐specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier , 2003, Glia.
[75] Seol-Heui Han,et al. Melatonin attenuates kainic acid‐induced hippocampal neurodegeneration and oxidative stress through microglial inhibition , 2003, Journal of pineal research.
[76] S. Heinemann,et al. Loss of Kainate Receptor-Mediated Heterosynaptic Facilitation of Mossy-Fiber Synapses in KA2−/− Mice , 2003, The Journal of Neuroscience.
[77] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[78] K. Flanders,et al. Kainate treatment alters TGF-beta3 gene expression in the rat hippocampus. , 2002, Brain research. Molecular brain research.
[79] M. Rincón,et al. The two faces of IL-6 on Th1/Th2 differentiation. , 2002, Molecular immunology.
[80] U. Hanisch,et al. Microglia as a source and target of cytokines , 2002, Glia.
[81] Y. Mitsuyama,et al. Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus , 2002, Experimental Brain Research.
[82] B. Winblad,et al. Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice , 2002, Brain Research.
[83] M. Pallàs,et al. Kainic acid‐induced neuronal cell death in cerebellar granule cells is not prevented by caspase inhibitors , 2002, British journal of pharmacology.
[84] David Lodge,et al. A Critical Role of a Facilitatory Presynaptic Kainate Receptor in Mossy Fiber LTP , 2001, Neuron.
[85] J. E. Lee,et al. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E2 production and neurodegeneration in cortical and hippocampal cell cultures , 2001, Brain Research.
[86] H. Wiesinger. Arginine metabolism and the synthesis of nitric oxide in the nervous system , 2001, Progress in Neurobiology.
[87] H. Prast,et al. Nitric oxide as modulator of neuronal function , 2001, Progress in Neurobiology.
[88] J. Hidalgo,et al. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures , 2001, Neuroscience.
[89] E. Suzuki,et al. Glufosinate ammonium stimulates nitric oxide production through N-methyl d-aspartate receptors in rat cerebellum , 2000, Neuroscience Letters.
[90] L. Illum. Transport of drugs from the nasal cavity to the central nervous system. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[91] E. Mackenzie,et al. Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[92] T. Kishimoto,et al. IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis1 , 2000, The Journal of Immunology.
[93] J. Velazquez,et al. Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy , 2000, Neuroscience.
[94] A. Hamberger,et al. Quantitative immunochemistry on neuronal loss, reactive gliosis and BBB damage in cortex/striatum and hippocampus/amygdala after systemic kainic acid administration , 2000, Neurochemistry International.
[95] C. Bendotti,et al. Differential Expression of S100β and Glial Fibrillary Acidic Protein in the Hippocampus after Kainic Acid-Induced Lesions and Mossy Fiber Sprouting in Adult Rat , 2000, Experimental Neurology.
[96] H. Kato,et al. The Initiation of the Microglial Response , 2000, Brain pathology.
[97] S. Sensi,et al. AMPA Exposures Induce Mitochondrial Ca2+ Overload and ROS Generation in Spinal Motor Neurons In Vitro , 2000, The Journal of Neuroscience.
[98] C. Greer,et al. Differential distribution of ionotropic glutamate receptor subunits in the rat olfactory bulb , 1999, The Journal of comparative neurology.
[99] Fred H. Gage,et al. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice , 1998, Nature.
[100] D. D. Hunter,et al. Expression of non-N-methyl-d-aspartate glutamate receptor subunits in the olfactory epithelium , 1997, Neuroscience.
[101] H. Hartung,et al. Transforming growth factor-β1: A lesion-associated cytokine of the nervous system , 1995, International Journal of Developmental Neuroscience.
[102] S. Yamashita,et al. Direct Drug Transport from the Rat Nasal Cavity to the Cerebrospinal Fluid: the Relation to the Molecular Weight of Drugs , 1995, The Journal of pharmacy and pharmacology.
[103] Richard J. Miller,et al. Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[104] T. Morgan,et al. TGF-β1 mRNA Increases in Macrophage/Microglial Cells of the Hippocampus in Response to Deafferentation and Kainic Acid-Induced Neurodegeneration , 1993, Experimental Neurology.
[105] C. Nathan,et al. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[106] Y. Ben-Ari,et al. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy , 1985, Neuroscience.
[107] Erik B. Bloss,et al. Hippocampal kainate receptors. , 2010, Vitamins and hormones.
[108] G. Swanson. Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon? , 2009, Neuropsychopharmacology.
[109] I. Cho,et al. Expression of Adenomatous Polyposis Coli Protein in Reactive Astrocytes in Hippocampus of Kainic Acid-Induced Rat , 2009, Neurochemical Research.
[110] Dong Woon Kim,et al. Role of microglial IKK b in kainic acid-induced hippocampal neuronal cell death , 2008 .
[111] R. Maccioni,et al. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. , 2008, Archives of medical research.
[112] Á. Simonyi,et al. Kainic acid-mediated excitotoxicity as a model for neurodegeneration , 2007, Molecular Neurobiology.
[113] C. Chung,et al. Glial Expression of Interleukin-18 and its Receptor After Excitotoxic Damage in the Mouse Hippocampus , 2007, Neurochemical Research.
[114] A. Volterra,et al. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. , 2007, International review of neurobiology.
[115] J. Lacaille,et al. Selective degeneration and synaptic reorganization of hippocampal interneurons in a chronic model of temporal lobe epilepsy. , 2006, Advances in neurology.
[116] V. Perry,et al. Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[117] L. Jarrard. Use of excitotoxins to lesion the hippocampus: Update , 2002, Hippocampus.
[118] G. Stoll,et al. Cytokines in CNS disorders: neurotoxicity versus neuroprotection. , 2000, Journal of neural transmission. Supplementum.
[119] U. Kompella,et al. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? , 1998, Journal of drug targeting.